Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Doubleblind, Randomized, Placebo-controlled, Multicenter Clinical Study to Investigate Relaps-prevention by Hypericumextract in Outpatients With Moderate Depressive Episodes (Major Depression)

NCT04315597 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT04315597
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04315597 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Doubleblind, Randomized, Placebo-controlled, Multicenter Clinical Study to Investigate Relaps-prevention by Hypericumextract in Outpatients With Moderate Depressive Episodes (Major Depression)
Lead sponsor
Bayer
Phase
Phase 3
Overall status
Completed
Start date
March 3, 2009
Completion date
November 22, 2011
Enrollment
398 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

moderate depressive episodes (major depression)